Literature DB >> 8305133

Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands.

B D Evavold1, J Sloan-Lancaster, P M Allen.   

Abstract

Recent observations of T-cell responses following T-cell receptor (TCR) interaction with altered peptide ligands have highlighted the complexity of this signalling system. The indications are that the TCR responds to minor changes in ligand with gradations of T-cell activation and effector functions. Brian Evavold, Joanne Sloan-Lancaster and Paul Allen review these studies and present a model in which partial T-cell activation and TCR antagonism are related events in a continuum of signalling through the TCR.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8305133     DOI: 10.1016/0167-5699(93)90200-5

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  116 in total

1.  Immunodominant epitopes in Babesia bovis rhoptry-associated protein 1 that elicit memory CD4(+)-T-lymphocyte responses in B. bovis-immune individuals are located in the amino-terminal domain.

Authors:  Junzo Norimine; Carlos E Suarez; Terry F McElwain; Monica Florin-Christensen; Wendy C Brown
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

Review 2.  Peptide-based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities.

Authors:  S M Anderton
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

3.  Dissociation of peripheral T cell responses from thymocyte negative selection by weak agonists supports a spare receptor model of T cell activation.

Authors:  Lisa K McNeil; Brian D Evavold
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

4.  Contrasting immunopathogenic properties of highly homologous peptides from rat and human thyroglobulin.

Authors:  V P Rao; G Carayanniotis
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

5.  Antigenic drift as a mechanism for tumor evasion of destruction by cytolytic T lymphocytes.

Authors:  Xue-Feng Bai; Jinqing Liu; Ou Li; Pan Zheng; Yang Liu
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 6.  Defining the parameters necessary for T-cell recognition of ligands that vary in potency.

Authors:  Neely E Kilgore; Mandy L Ford; Carrie D Margot; Daniel S Jones; Peter Reichardt; Brian D Evavold
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 7.  Dengue: defining protective versus pathologic immunity.

Authors:  Alan L Rothman
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

8.  Antagonistic peptide technology for functional dissection of CLV3/ESR genes in Arabidopsis.

Authors:  Xiu-Fen Song; Peng Guo; Shi-Chao Ren; Ting-Ting Xu; Chun-Ming Liu
Journal:  Plant Physiol       Date:  2013-01-15       Impact factor: 8.340

Review 9.  Suboptimal engagement of the T-cell receptor by a variety of peptide-MHC ligands triggers T-cell anergy.

Authors:  Scheherazade Sadegh-Nasseri; Sarat K Dalai; Laura C Korb Ferris; Saied Mirshahidi
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

10.  Inhibition of intrathymic T cell development by expression of a transgenic antagonist peptide.

Authors:  C N Levelt; E Mizoguchi; X Huang; R Zacks; A K Bhan; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.